Evidence map›Paper›PMID 32848925›Full record

SynthesisFrontiers in psychiatry2020

Neuropsychological and Psychiatric Features of Children and Adolescents Affected With Mitochondrial Diseases: A Systematic Review.

Elise Riquin, Philippe Duverger, Cindy Cariou, Magalie Barth, Clément Prouteau, Patrick Van Bogaert, Dominique Bonneau, Arnaud Roy

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. mitoTALEN reduces the mutant mtDNA load in neurons.Molecular therapy. Nucleic acids · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Recent advances in mitochondrial diseases: From molecular insights to therapeutic perspectives.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Elise RiquinDepartment of Child and Adolescent Psychiatry, University Hospital of Angers, Angers, France.
Philippe DuvergerDepartment of Child and Adolescent Psychiatry, University Hospital of Angers, Angers, France.
Cindy CariouDepartment of Child and Adolescent Psychiatry, University Hospital of Angers, Angers, France.
Magalie BarthDepartment of Biochemistry and Genetics, University Hospital of Angers, Angers, France.
Clément ProuteauDepartment of Biochemistry and Genetics, University Hospital of Angers, Angers, France.
Patrick Van BogaertDepartment of Pediatric Neurology, Angers University Hospital, Angers, France.
Dominique BonneauMitovasc Unit, UMR CNRS 6015-INSERM 1083, Angers, France.
Arnaud RoyLaboratory of Psychology, LPPL EA4638, University of Angers, Angers, France.
Centre Hospitalier Universitaire d'Angers · FRCentre National de la Recherche Scientifique · FRCentre Hospitalier Universitaire de Nantes · FRLaboratoire de Psychologie des Pays de la Loire · FRUnité de recherche sur les maladies cardiovasculaires et métaboliques · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial diseases (MDs) are a group of clinically heterogeneous genetic disorders that arise as the result of dysfunctional mitochondria. Only few medical articles deal with neuropsychological or psychiatric aspects of MDs.

aimThe present article aims to provide a systematic review of neuropsychological and psychiatric aspects of MDs.

methodsIn order to identify all studies dealing with psychiatric and neuropsychological aspects of MDs in children and adolescents, we performed a search in the medical literature between April 2009 and April 2019 using PubMed, Cochrane, and Web of Science and we defined inclusion and exclusion criteria.

resultsWe found only seven studies that satisfy the inclusion requirements and criteria. The main psychiatric aspects reported in MDs were depressive and behavioral disorders. With regard to the neuropsychological aspects of MDs, developmental analyses showed an overall deterioration and developmental delay.

interpretationChildren and adolescents with MDs may present psychiatric symptoms and neuropsychological impairment. A more systematic investigation of psychiatric and neuropsychological features of MDs is needed to foster a better understanding of the phenotype of these diseases and their links with the genotype, which may have significant implications for the developmental trajectories of patients.

Indexed as

adolescentchildrenmitochondrial diseasesneuropsychological profilepsychiatric profile

Identifiers

PMID32848925
PMCPMC7399331
OpenAlexW3046195293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.